Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8941 |
High Similarity |
NPD6559 |
Discontinued |
0.8929 |
High Similarity |
NPD3818 |
Discontinued |
0.8788 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8701 |
High Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8547 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8521 |
High Similarity |
NPD6959 |
Discontinued |
0.8497 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8471 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8439 |
Intermediate Similarity |
NPD7054 |
Approved |
0.843 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8424 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8409 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8409 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8391 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8383 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8383 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.837 |
Intermediate Similarity |
NPD6781 |
Approved |
0.837 |
Intermediate Similarity |
NPD6780 |
Approved |
0.837 |
Intermediate Similarity |
NPD6782 |
Approved |
0.837 |
Intermediate Similarity |
NPD6776 |
Approved |
0.837 |
Intermediate Similarity |
NPD6778 |
Approved |
0.837 |
Intermediate Similarity |
NPD6779 |
Approved |
0.837 |
Intermediate Similarity |
NPD6777 |
Approved |
0.8344 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8344 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8344 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8343 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8343 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8295 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8249 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8249 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.8229 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8214 |
Intermediate Similarity |
NPD37 |
Approved |
0.8214 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8211 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.8187 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD4966 |
Approved |
0.8176 |
Intermediate Similarity |
NPD4965 |
Approved |
0.8176 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8176 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.8176 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8166 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8161 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8161 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8161 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8144 |
Intermediate Similarity |
NPD3226 |
Approved |
0.814 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8138 |
Intermediate Similarity |
NPD7697 |
Approved |
0.8138 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.8138 |
Intermediate Similarity |
NPD7698 |
Approved |
0.8121 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8118 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8098 |
Intermediate Similarity |
NPD6534 |
Approved |
0.8098 |
Intermediate Similarity |
NPD6535 |
Approved |
0.8095 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.8095 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.8068 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.8068 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8063 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.8059 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8047 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8023 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8012 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7989 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7989 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7988 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7979 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7979 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7978 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7968 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7968 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7938 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7938 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7938 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7914 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7914 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7907 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7853 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7844 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7844 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7841 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7833 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7814 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7812 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7811 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7797 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7772 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7771 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7759 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7758 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7754 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7754 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7751 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7746 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.774 |
Intermediate Similarity |
NPD5710 |
Approved |
0.774 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7738 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7706 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7697 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7676 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7654 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7641 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7616 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7605 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD920 |
Approved |
0.7598 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7586 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7543 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7541 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.753 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.753 |
Intermediate Similarity |
NPD6100 |
Approved |
0.753 |
Intermediate Similarity |
NPD6099 |
Approved |
0.753 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7488 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7488 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7485 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7472 |
Intermediate Similarity |
NPD919 |
Approved |
0.7459 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7456 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7427 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7384 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD7930 |
Approved |
0.7368 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7365 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7345 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7345 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7282 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7256 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.725 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7246 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7241 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7229 |
Intermediate Similarity |
NPD943 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7219 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7212 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7212 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7209 |
Intermediate Similarity |
NPD6190 |
Approved |
0.72 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7196 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7189 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7186 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7176 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7163 |
Intermediate Similarity |
NPD8366 |
Approved |
0.716 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.715 |
Intermediate Similarity |
NPD7999 |
Approved |
0.7136 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7126 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7126 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7097 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7093 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7077 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7077 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7076 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7059 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD8067 |
Phase 3 |
0.7052 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7048 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7041
|
Intermediate Similarity |
NPD4361 |
Phase 2 |